Four-arm polypropylene mesh for vaginal vault prolapse-surgical technique and outcomes.


Journal

European journal of obstetrics, gynecology, and reproductive biology
ISSN: 1872-7654
Titre abrégé: Eur J Obstet Gynecol Reprod Biol
Pays: Ireland
ID NLM: 0375672

Informations de publication

Date de publication:
Dec 2020
Historique:
received: 29 06 2020
revised: 02 10 2020
accepted: 08 10 2020
pubmed: 6 11 2020
medline: 15 5 2021
entrez: 5 11 2020
Statut: ppublish

Résumé

Advanced vaginal vault prolapse (VVP) can occur rarely after any type of hysterectomy. Several types of procedures have been applied to correct this defect, but optimal management is still pending. The aim of this study was to describe the surgical technique and results of four-arm transvaginal mesh (FATVM) application for advanced VVP. We followed up for 24 months, 160 patients with VVP > II vc (according to the Pelvic Organ Prolapse Quantification Scale (POPQ)), who underwent FAMTVM from 2014 to2017. FAMTVM was inserted with the anterior arms through the obturator foramens and the posterior arms through the ischiorectal fossas and sacrospinal ligaments. Clinical data were prospectively collected in a customized database and retrospectively analyzed. To assess QoL SF 36, KHQ and FSFI questionnaires were used. POPQ was employed to measure degree of VVP. Non-parametric tests (The Wilcoxon signed-rank test) were applied to verify statistical hypotheses. According to SF 36, significant improvement was evident in almost all aspects of general QoL (PCS p = 0.002, MCS p = 0.01). KHQ showed statistically significant improvement in all domains. FSFI scores after surgery indicated significantly improvement in all domains of the questionnaire, apart from lubrication (p = 0.02). Intraoperative bladder injury occurred in 3.75 % (n = 6) of all cases. Five patients (3.1 %) complained of de novo stress urinary incontinence. VVP reoccurred in nine cases (5.6 %). Only two patients (1.25 %) saw mesh exposure after 6 months postoperative recovery. We consider FAMTVM for VVP to be safe and effective. Hence, it applied as an optional treatment, especially in patients with contraindications to laparotomy and laparoscopy.

Identifiants

pubmed: 33152564
pii: S0301-2115(20)30637-0
doi: 10.1016/j.ejogrb.2020.10.007
pii:
doi:

Substances chimiques

Polypropylenes 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

203-210

Informations de copyright

Copyright © 2020 Elsevier B.V. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors reported no declarations of interest.

Auteurs

Katarzyna A Skorupska (KA)

2nd Department of Gynecology, Medical University of Lublin, Poland. Electronic address: kasiaperzylo@hotmail.com.

Konrad Futyma (K)

2nd Department of Gynecology, Medical University of Lublin, Poland.

Michał Bogusiewicz (M)

2nd Department of Gynecology, Medical University of Lublin, Poland.

Ewa Rechberger (E)

2nd Department of Gynecology, Medical University of Lublin, Poland.

Alicja Ziętek-Strobl (A)

2nd Department of Gynecology, Medical University of Lublin, Poland.

Paweł Miotła (P)

2nd Department of Gynecology, Medical University of Lublin, Poland.

Andrzej Wróbel (A)

2nd Department of Gynecology, Medical University of Lublin, Poland.

Tomasz Rechberger (T)

2nd Department of Gynecology, Medical University of Lublin, Poland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH